Drug Profile
Research programme: PCSK 9 inhibitors - Pfizer/ University of Queensland Institute for Molecular Bioscience
Alternative Names: PCSK 9 vaccine - PfizerLatest Information Update: 22 Aug 2023
Price :
$50
*
At a glance
- Originator Pfizer; University of Queenslands Institute for Molecular Bioscience
- Class Peptides; Small molecules; Vaccines
- Mechanism of Action PCSK9 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cardiovascular disorders; Lipid metabolism disorders
Most Recent Events
- 22 Aug 2023 Discontinued - Preclinical for Cardiovascular disorders in USA (Parenteral, Injection)
- 22 Aug 2023 Discontinued - Preclinical for Cardiovascular disorders in USA (PO)
- 22 Aug 2023 Discontinued - Preclinical for Lipid metabolism disorders in USA (Parenteral, Injection)